Screening for familial ovarian cancer--management and outcome of women with moderate to high risk of developing ovarian cancer

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
G C RieckA N Fiander

Abstract

Five percent to ten percent of ovarian cancers are hereditary. Individual genetic risk of developing ovarian malignancy is discussed in women. Currently, prophylactic surgery is advised to women with a moderate to high risk of developing ovarian cancer. Workload and outcome of the multidisciplinary familial ovarian screening clinic in South Wales were assessed. This was an observational study of 145 women registered with the Familial Ovarian Screening Clinic between January 1998 and December 2003. The data were retrieved from the medical notes. Yearly follow-ups were investigated with a transvaginal scan and CA125 level. Post-surgery women were followed up with yearly CA125 estimations: 46.9% fell into moderate-risk and 50.3% into high-risk category. The median age was 42 (SD 10.4), 71.7% were pre menopausal, and 10.3% had a personal history of breast cancer and 1.4% colon cancer. Whereas 36.5% opted for surgery, the remaining women (but two) opted for annual follow-up. Histology of the women who had surgery showed three cases of malignancies (fallopian tube carcinoma, atypical ovarian epithelial cells, and metastatic breast cancer). Seven women developed breast cancer during the observation period. The follow-up period is too ...Continue Reading

References

Dec 28, 1992·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M A van EijkerenF H van Etten
Oct 14, 1992·JAMA : the Journal of the American Medical Association·C I AmosP Hartge
Nov 1, 1991·Gynecologic Oncology·T H BourneW P Collins
Jun 1, 1991·Cancer Genetics and Cytogenetics·H T LynchJ Lynch
Jan 1, 1987·Advances in Cancer Research·R L Prentice, D B Thomas
Sep 1, 1988·American Journal of Epidemiology·J M Schildkraut, W D Thompson
Dec 1, 1981·International Journal of Cancer. Journal International Du Cancer·N S WeissJ R Daling
Jan 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J ChangM E Gore
Dec 20, 1995·International Journal of Cancer. Journal International Du Cancer·M AarnioH J Järvinen
Jun 11, 1997·International Journal of Cancer. Journal International Du Cancer·A GreenB Ward
Aug 1, 1997·International Journal of Epidemiology·N KreigerP Parsons
Jan 15, 1998·Nature·A HemminkiL A Aaltonen
Feb 18, 1998·American Journal of Obstetrics and Gynecology·R P ZweemerF H Menko
May 21, 1998·The New England Journal of Medicine·L A AaltonenA de la Chapelle
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·S SutcliffeB A Ponder
Dec 13, 2000·Gastroenterology·F M GiardielloJ A Offerhaus
May 25, 2002·The New England Journal of Medicine·Noah D KauffKenneth Offit
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
Sep 19, 2002·Journal of the National Cancer Institute·Marcia S BroseBarbara L Weber
Feb 15, 2003·Gynecologic Oncology·Robert F OzolsMolly A Brewer
Apr 22, 2003·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·A TailorW P Collins
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
Nov 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Douglas A LevineJeff Boyd
Dec 12, 2003·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Maria L CarcangiuBarbara Pasini
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sunil R LakhaniDouglas F Easton
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Bethan PowellJohn Ziegler
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Diane StirlingMary E Porteous
May 11, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Adam N Rosenthal

❮ Previous
Next ❯

Citations

Jan 26, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yoland AntillKelly-Anne Phillips

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.